Emergex CEO Questions mRNA Vaccines Against ‘Wuhan Virus’, Works On Universal Vaccines

episode

Citeline Podcasts not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Your partner wants profit. You want freedom. Now what? 22 min · 16 Sep 2026 · The Optometry Success Podcast

Board of County Supervisors Meeting - Work Session - Sep 15, 2026 3h 17m · 15 Sep 2026 · Prince William County Board of Supervisors

Finance and Budget Committee - Sep 15, 2026 1h 43m · 15 Sep 2026 · Prince William County Finance and Budget Committee

The Art of True Happiness | Dr. Arthur Brooks 2h 49m · 14 Sep 2026 · Huberman Lab

The Chris Wolfe Podcast: The Power of Quality Supplements 48 min · 14 Sep 2026 · EyeCode Media

Brisbane coach Chris Fagan (14.09.26) 10 min · 13 Sep 2026 · SEN Breakfast

Report any issue

Source

Recorded31 Aug 2023

Publisherfeeds.soundcloud.com ↗

Handlerec:4678230

Show notes

Scrip’s senior editor Vibha Ravi speaks with Dr Thomas Rademacher, Emergex CEO and ex-research director at the University of Oxford, about the myth of the “Wuhan virus” and why synthetic T-cell adaptive vaccines are expected to be superior to RNA/mRNA ones. Novel delivery mechanisms like patches and microneedles are part of the UK-based clinical-stage biotech’s plan to make universal coronavirus and influenza vaccines affordable and effective as it seeks to partner governments. https://scrip.pharmaintelligence.informa.com/SC148976/Emergex-CEO-Questions-mRNA-Vaccines-Against-Wuhan-Virus-Works-On-Universal-Vaccines

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in